These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3771816)

  • 21. Psychotic symptoms following buprenorphine withdrawal.
    Karila L; Berlin I; Benyamina A; Reynaud M
    Am J Psychiatry; 2008 Mar; 165(3):400-1. PubMed ID: 18316438
    [No Abstract]   [Full Text] [Related]  

  • 22. Diazepam withdrawal syndrome: a case with psychosis, seizure, and coma.
    de Bard ML
    Am J Psychiatry; 1979 Jan; 136(1):104-5. PubMed ID: 103443
    [No Abstract]   [Full Text] [Related]  

  • 23. [Complications of drug withdrawal from antiparkinson agents and neuroleptics].
    Mizon JP; Rosa A
    Therapie; 1984; 39(4):421-5. PubMed ID: 6148792
    [No Abstract]   [Full Text] [Related]  

  • 24. Nomifensine--a farewell and future concerns.
    Shader RI; Greenblatt DJ
    J Clin Psychopharmacol; 1986 Jun; 6(3):A21. PubMed ID: 3711362
    [No Abstract]   [Full Text] [Related]  

  • 25. Propranolol withdrawal in psychosis.
    Rosenthal S; Ellison J
    Am J Psychiatry; 1990 Apr; 147(4):534-5. PubMed ID: 2316745
    [No Abstract]   [Full Text] [Related]  

  • 26. More data on supersensitivity psychosis.
    Witschy JK; Malone GL; Holden LD
    Am J Psychiatry; 1984 Oct; 141(10):1302. PubMed ID: 6148896
    [No Abstract]   [Full Text] [Related]  

  • 27. [Central anticholinergic syndrome in intensive care patients].
    Brede S; Dennhardt R
    Klin Wochenschr; 1991; 69 Suppl 26():89-94. PubMed ID: 1813736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychoses associated with propranolol withdrawal.
    Golden RN; Hoffman J; Falk D; Provenzale D; Curtis TE
    Biol Psychiatry; 1989 Feb; 25(3):351-4. PubMed ID: 2914157
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuroleptic-induced supersensitivity psychosis, the "hump course," and tardive dyskinesia.
    Chovinard G; Jones B
    J Clin Psychopharmacol; 1982 Apr; 2(2):143-4. PubMed ID: 6122695
    [No Abstract]   [Full Text] [Related]  

  • 30. Death following suspected alprazolam withdrawal seizures: a case report.
    Haque W; Watson DJ; Bryant SG
    Tex Med; 1990 Jan; 86(1):44-7. PubMed ID: 2300914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interruption of Catapresan therapy as a cause of severe crisis in a patient].
    Svensson A
    Lakartidningen; 1983 Sep; 80(39):3591-2. PubMed ID: 6633082
    [No Abstract]   [Full Text] [Related]  

  • 32. Bromocriptine-related psychosis and treatment.
    Shukla S; Turner WJ; Newman G
    Biol Psychiatry; 1985 Mar; 20(3):326-8. PubMed ID: 3884056
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute psychosis associated with abrupt withdrawal of carbamazepine following intoxication.
    Darbar D; Connachie AM; Jones AM; Newton RW
    Br J Clin Pract; 1996 Sep; 50(6):350-1. PubMed ID: 8983329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychiatric disorder and diethylpropion hydrochloride.
    Carney MW; Harris M
    Practitioner; 1979 Oct; 223(1336):549-52. PubMed ID: 523407
    [No Abstract]   [Full Text] [Related]  

  • 35. On psychiatric syndromes associated with cannabis.
    Hart RH
    Ala Med; 1984 Aug; 54(2):34-6. PubMed ID: 6332510
    [No Abstract]   [Full Text] [Related]  

  • 36. Can oestrogen use prevent the onset of psychosis?
    Dhillon R; Bastiampillai T; Mohan T; Khor L
    Aust N Z J Psychiatry; 2013 Jul; 47(7):682-3. PubMed ID: 23439316
    [No Abstract]   [Full Text] [Related]  

  • 37. [The concept of supersensitivity psychosis. The particular case of clozapine].
    Llorca PM; Penault F; Lançon C; Dufumier E; Vaiva G
    Encephale; 1999; 25(6):638-44. PubMed ID: 10668609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nomifensine and psychological dependence--a case report.
    Böning J; Fuchs G
    Pharmacopsychiatry; 1986 Sep; 19(5):386-8. PubMed ID: 3774872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. gamma-Hydroxybutyrate withdrawal and chloral hydrate.
    Hutto B; Fairchild A; Bright R
    Am J Psychiatry; 2000 Oct; 157(10):1706. PubMed ID: 11007738
    [No Abstract]   [Full Text] [Related]  

  • 40. Gamma-hydroxybutyrate withdrawal syndrome.
    Dyer JE; Roth B; Hyma BA
    Ann Emerg Med; 2001 Feb; 37(2):147-53. PubMed ID: 11174231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.